Hamdan Medical Journal (previously the Journal of Medical Sciences)
|Table of Contents|
Neonatal Sepsis in the Very Low Birth Weight Preterm Infants: Part 1: Review of Patho-physiology
Background: Over the last fifty years neonatal care has made tremendous progress; increasing survival, reducing morbidity, developing newer modalities of care and therapy for the very low birth weight (VLBW) and premature infant. However, mortality from neonatal sepsis in this group of infants has remained between 18-20% in the developed world and around 80% in the developing world for last three decades with little sign of decline. There is also clear evidence that VLBW infants
who survive infection in the neonatal period are at significantly greater risk of neuro-developmental delay; making sepsis the most important cause of mortality and morbidity in this group of infants today.
Objective: The objective of this review is to highlight the reasons for this lack of success in combating neonatal sepsis successfully. These can be attributed to four main reasons; 1) poor host defences, 2) clinician’s inability to diagnose sepsis early and accurately [due to lack of or general availability of highly sensitive and specific markers], 3) clinician’s poor understanding of the ‘process’ i.e. pathophysiology of neonatal sepsis, thus not being able to institute early ‘goal’ directed therapy, and 4)
total reliance on killing the pathogen(s) with inadequate attention to correcting the consequences of the inflammatory process itself. This review presents a brief epidemiological background to neonatal infections in the VLBW infants, discusses host defence systems and how immune compromised VLBW infant combats infection by describing the pathophysiological ‘process’ of sepsis in detail. It is our belief that understanding the heterogeneity and complexity of host response and the defence systems is fundamental in formulating management strategies.
Conclusion: By discussing patho-physiology, current available diagnostic tests and presenting an evidence based management ‘care bundle’ it is hoped to change clinician's paradigm to use more immune and molecular markers for diagnosis and monitoring of the infection process and in management considering adjunctive therapies that boost host defences. It is recognised that while this review is static i.e. it presents evidence as we understand it today, sepsis is a dynamic process. Our understanding, ability to diagnose and manage neo-natal sepsis is constantly changing and will continue to change and evolve. By presenting this review it is hoped that over a period of time more of our practices would become evidence based and dogma abandoned.
Modi N, Carr R. Promising Stratagems for reducing the burden of neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2000; 83: F150-3.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-Onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal Research Network. Pediatrics 2002;110: 285-91.
Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the cause of four million neonatal deaths in the year 2000. Int J Epidemiol 2006; 35: 706-18.
Haque KN. Infection and Immunity in the newborn. In: McIntosh N, Helms P (Eds). Textbook of Paediatrics.6th edition. Churchill Livingstone, Edinburgh 2003; pp. 273-90.
Stoll BJ, Hansen N. Infection in very low-birth weight infants. Studies from NICHD Neonatal Network.Semin Perinatol 2003; 27: 293-301.
Ferrieri P. Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis 1990;12(Suppl 4): S394-400.
Haque KN. Understanding and optimising outcome in neonates with sepsis and septic shock. Year book of Intensive Care and Emergency Medicine. In: Vincent JL, Ed. Springer: USA 2007; pp. 55-68.
Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neuro development and growth impairment among extremely low birthweight infants with neonatal infections. JAMA 2004;292: 2357-65.
Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL,Johnson AM. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995; 346: 1449-54.
Mittendorf R, Covert R, Kohn J, Roizen N, Khoshnood B, Lee KS. The association of CONS isolated from chorioamnion at delivery and subsequent development of CP. J Perinatol 2001; 21: 3-8.
Dammann O, Leviton A. Infections remote from brain; neonatal white matter damage and CP in preterm infants. Semin Pediatr Neurol 1998; 5: 190-201.
Escobar GJ. The neonatal ‘sepsis workup’: Personal reflections on the development of an evidence based approach toward newborn infections in a managed care organisation. Pediatrics 1999; 103:360-73.
Schrag SJ, Stoll BJ. Early onset neonatal sepsis in the era of wide spread of intrapartum chemoprophylaxis.Pediatr Infect Dis J 2006; 25: 939-40.
Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Childhealth and Human development Neonatal Research Network. 2002-2003. Pediatr Infect Dis J 2005; 24(7): 635-9.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late onset sepsis in very low birth weight neonates: the experience of NICHD Neonatal Research Network. Pediatrics 2002; 110(2 pt 1): 285-91.
Rahman S, Hameed A, Roghani MT, Ulla Z. Multi drug resistant neonatal sepsis in Peshawar, Pakistan. Arch Dis Child Fetal Neonatal Ed 2002; 87: F52-4.
Rønnestad A, Abrahamsen TG, Medbø S, Reigstad H, Lossius K, Kaaresen PI, et al. Septicaemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics 2005; 115:e262-8.
Haque KN, Khan MA, Kerry S, Stephenson J, Woods G. Pattern of neonatal sepsis in a district general hospital in UK. Infect Control Hosp Epidemiol 2004;25: 759-64.
Graham PL 3rd, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risk factors for late onset Gramnegative sepsis in low birth weight infants hospitalised in intensive care units. Pediatr Infect Dis J 2006;25: 113-7.
Cartlidge P. The epidermal barrier. Semin Neonatol 2000; 5: 273-80.
Darmstadt GL, Saha SK, Ahmed AS, Ahmed S, Chowdhury MA, Law PA, et al. Effects of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled,clinical trial. Pediatrics 2008; 121: 522-9.
Seidel BM, Schulze B, Schubert S, Borte M. Oral mucosal incompetence in preterm infants in the first nine months of life. Eur J Paediatr 2000; 159: 789.
Rognum TO, Thrane S, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992; 32: 145-9.
Saiman L. Risk factors for hospital acquired infections in neonatal intensive care units. Semin Perinatol 2002; 26: 315-21.
Garcia AM, Fadel SA, Cao S, Sarzotti M. T-Cell immunity in neonates. Immunol Res 2000; 22: 177-90.
Trivedi HN, HayGlass KT, Gangur V, Allardice JG, Embree JE, Plummer FA. Analysis of neonatal T-cells and antigen presenting cell function. Hum Immunol 1997; 57: 69-79.
Carr R, Huizinga TW. Low soluble FcRIII receptor demonstrates reduced neutrophils reserves in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000;83: F160.
Urlichs F, Speer CP. Neutrophil function in preterm and term infants. Neo Rev 2004; 10: 417-30.
Lorant DE, Li W, Tabatabaei N, Garver MK, Albertine KH. P-Selectin expression by endothelial cells is decreased in neonatal rats and human premature infants.Blood 1999; 94: 600-9.
Drossou V, Kanakoudi F, Tzimouli V, Sarafidis K,Taparkou A, Bougiouklis D, et al. Impact of prematurity, stress and sepsis on the neutrophils respiratory burst activity of neonates. Biol Neonatal 1997; 72:201-9.
Kohl S, Sigouroudinia M, Engleman EC. Adhesion defects of antibody-mediated target cells binding of neonatal natural killer cells. Pediatr Res 1999; 46:755-9.
Schelonka RL, Infante AJ. Neonatal immunology.Semin Perinatol 1998; 22: 2-14.
Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose binding lectin. Intensive Care Med 2004; 30: 1263-5.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54. (Erratum p. 1376).
Mire-Sluis AR, Thorpe R (Eds) In: Cytokines. San Diego, California Academic Press 1998.
Härtel C, Osthues I, Rupp J, Haase B, Röder K, Göpel W, et al. Characterisation of host inflammatory response to Staphylococcus epidermidis in neonatal whole blood. Arch Dis Child Fetal Neonatal Ed 2008; 93: F140-5.
Tonegawa S. Somatic generation of antibody diversity.Nature 1998; 302: 575-81.
Abbas AK, Litchman AH, Prober JS. General properties of Immune response. In: Cellular and Molecular Immunology. Abbas AK (Ed), 3rd Edition. Philadelphia 1997; p. 4-33. Sompayrac L. How immune system works? Malden MA (Ed). Blackwell Science Inc 1999.
Haque KN, Remo C, Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol 1995; 10:328-33.
Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, et al. Sterotyped and specific gene expression programs in human innate response to bacteria. Proc Nat Acad Sci USA 2002; 99: 972-7.
Dahmer MK, Randolph A, Vitali S, Quasney MW.Genetic polymorphism in sepsis. Pediatr Crit Care Med 2005; 6(3): 61-73.
Hardin T, Dipiro JT. Sepsis and Septic Shock. In:Pharmacotherapy. Appleton and Lange; Stanford Press 1999: pp. 1838-927.
Nau GJ, Richmond JF, Schlesinger A, Jennings EG,Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Pro Nat Acad Sci USA 2002; 99: 1503-8.
Sáez-Llorens X, McCracken GH Jr. Sepsis syndrome and septic shock in paediatrics: Current concepts,terminology, Pathophysiology and management. J Paediatr 1993; 123: 497-508.
Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al. Bacterial Endotoxins sensitises the brain to hypoxic ischemic injury. Eur J Neurosci 2001; 13: 1011-20.
Duggan PJ, Maalouf EF, Watts TL, Sullivan MH,Counsell SJ, Allsop J, et al. Intrauterine T cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 385: 1699-701.
Elovitz MA, Mrinalini C, Sammel MD. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm births. Pediatr Res 2006; 59:50-5.